1: Cracking the biosimilar code with Biocon’s Kiran Mazumdar Shaw

2: The pharma trends and stocks that really matter

3: Decoding the US drug regulator’s actions on pharma plants

4: Everything that you wanted to ask about investing in pharma stocks

5: Tracking the pharma pulse

6: The best pharma bets, according to this CIO who manages investments worth Rs 500 crore

7: The bitter truth about sugar in your diet

8: Heard of the Keto Diet? It was the most googled diet of 2018. What is it?

9: The man behind transforming Aamir Khan in Dangal thinks obesity is a disease. Here's why

10: What is your gut instinct on health? Find out!

11: Obesity: The Big Picture — With Dr Dixit of 'The Dixit Diet' fame

12: Luke Coutinho on holistic approach to life with integrative and lifestyle medicine

13: The big biosimilar opportunity, according to Morgan Stanley

15: Generic drug sales growth in US to slow down?

16: Recovery in the pharma sector is likely to be slow

17: Biologics and complex chemistry will dominate pharma sector over the next 5 years, says Deepak Mallik of Edelweiss

18: Anmol Ganjoo of JM Financial believes pharma sector’s recovery will be uneven

19: The Medicine Box: Kapil Khandelwal of Toro Finserve LLP on Indian healthcare space, consolidation and growth

20: What's trending in pharma & healthcare space

21: The Medicine Box: Wolters Kluwer CEO Shireesh Sahai talks about UpToDate app

22: Research Delta's Nimish Mehta talks about Para IV and potential opportunities

24: Innovation in healthcare policymaking

25: Healthcare financing models in India

26: public & private partnerships in healthcare

27: Emerging business models in the pharmaceutical industry

28: Research and development in healthcare

29: The Medicine Box: Rehan Khan talks about launch of MSD India's gender-neutral HPV vaccine

30: The Medicine Box: Kearney’s Saumya Krishna explains how ‘Make In India’ can fuel 4x growth in vaccines, biosimilars by 2026

31: The Medicine Box: Kiran Mazumdar-Shaw on biosimilar interchangeable status for Biocon's diabetes drug

32: The Medicine Box: Twin Health's Jahangir Mohammad on reversing chronic diseases like diabetic

33: The Medicine Box: Tata 1MG founder Prashant Tandon on India’s health tech market

34: The Medicine Box: AstraZeneca’s Dr Anil Kukreja on Project Heartbeat, health tech

35: The Medicine Box: JB Chemical's Nikhil Chopra on factors driving domestic pharma market’s growth

36: The Medicine Box Podcast: India can become leader of innovative drugs, funding huge challenge, says Dr Reddy’s GV Prasad

37: The Medicine Box: Home health, telemedicine here to stay? Fortis head Dr Ashutosh Raghuvanshi explains

38: The Medicine Box: Torrent Pharma eyes double digital domestic growth, cardiology key focus, says ED Aman Mehta

39: The Medicine Box: Cipla’s Umang Vohra on COVID-19 portfolio, upcoming drugs, US business outlook and more

40: The Medicine Box: Zydus Lifesciences MD Sharvil Patel on rebranding after nearly 3 decades

14: The new emerging trends in pharma sector according to Prashant Nair of Citi